Skip to main content
  • Home
  • About
  • Faculty Experts
  • For The Media
  • Videos
  • Topics
    • Alumni
    • Events
    • Faculty
    • Library
    • Research
    • Students
    • All Topics
  • Contact
  • Submit
STEM
  • All News
  • Arts & Culture
  • Business & Economy
  • Campus & Community
  • Health & Society
  • Media, Law & Policy
  • STEM
  • Veterans
  • |
  • Alumni
  • The Peel
  • Athletics
Sections
  • All News
  • Arts & Culture
  • Business & Economy
  • Campus & Community
  • Health & Society
  • Media, Law & Policy
  • STEM
  • Veterans
  • |
  • Alumni
  • The Peel
  • Athletics
  • Home
  • About
  • Faculty Experts
  • For The Media
  • Videos
  • Topics
    • Alumni
    • Events
    • Faculty
    • Library
    • Research
    • Students
    • All Topics
  • Contact
  • Submit
STEM

Physics Ph.D. Student Builds Successful Research Company

Tuesday, November 21, 2017, By Cyndi Moritz
Share
College of Arts and SciencesentrepreneurshipStudents

Aaron Wolfe expects to finish up his Ph.D. in physics this semester. He has been working on his doctorate since 2011 and should have been done by now, he says, but a few things have gotten in the way—like helping to run a company, Ichor Therapeutics, of which he is chief operating officer.

Aaron Wolfe, Ellie Jumen

Aaron Wolfe shows Ellie Iumen what plasmids to use for a protein production run at Ichor Therapeutics.

“I have always wanted to run a biotech company,” Wolfe says. And in fact, he co-founded a company once before. This was after he got his bachelor’s degree at SUNY College of Environmental Science and Forestry in biotechnology and completed coursework in finance and entrepreneurism at the University of Pennsylvania’s Wharton School. His company brought a product to market, but like most startups, it failed, and he moved on.

In the College of Arts and Sciences, Wolfe has studied under Liviu Movileanu, program director of what is known as the SB3 graduate program, which includes structural biology, biochemistry and biophysics. Wolfe calls it a place for people who don’t “fit in a box.”

There, he worked closely with Adam Blanden, who was enrolled in a dual M.D./Ph.D. program with Upstate Medical University. In 2015, the two established Finger Lakes Bio, a startup drug and biologic development company.

Wolfe is still the CEO of Finger Lakes Bio, but his entrepreneurial fingerprint has grown since 2015 to include co-founding RecombiPure, a company that builds research tools, and Antoxerene, which does small-molecule drug discovery. Along with this he is acting as COO of Lysoclear, which does research on macular degeneration, and Ichor Therapeutics, which is a profitable contract research organization. He is doing all this with the help of his partners Blanden and Kelsey Moody (another former Upstate medical student).

Moody established Ichor in 2013 in his living room during medical school and has been growing the company ever since; Ichor is now in its third location. After visiting the facility, it is clear that Ichor is thriving. Its capital is increasing each year and Wolfe proudly points to the state-of-the-art equipment around the company’s LaFayette, New York, labs. The component companies have been able to attract contracts and investment just through word of mouth.

The atmosphere around the lab is casual but bustling. On a tour, Wolfe points out interns from several local colleges, and one of the scientists boasts about having purified several new proteins over the past week, when a typical lab might achieve one such purification in a month.

Ichor is always seeking to move into new areas, Wolfe says, and its website confirms this: “Fundamental to the Ichor culture is an emphasis on professional development. Our backgrounds span diverse disciplines in the life sciences, engineering, computer science and business. Team members are encouraged to embrace this diversity as a professional development opportunity, and to obtain cross training in areas unrelated to their core competencies,” it states.

Employees at work at Ichor Therapeutics

Employees at work at Ichor Therapeutics

Along with Ichor’s 19 employees, interns at Ichor come from several educational institutions around the area, including Syracuse and SUNY ESF. Wolfe is proud that the company is able to help students just starting out pursue their research dreams.

Wolfe says earning a doctorate has been advantageous in achieving his goal of running a successful biotech company. “Having a Ph.D. gives me a baseline credibility,” he comments. “When we move up to the next level of funding it will be especially helpful.”

He credits his advisor, Movileanu, with being “very gracious and patient” during the long period it took him to complete the work toward his degree. “I was able to work with him fairly autonomously for five years, which was extremely beneficial.”

Wolfe always knew he didn’t want to use his Ph.D. to climb the academic ladder. He’s actually right where he wants to be. He just wants to keep building his company.

  • Author

Cyndi Moritz

  • Recent
  • Drama Department to Virtually Present New Theatrical Work Inspired by University’s 150th Anniversary
    Saturday, January 23, 2021, By Erica Blust
  • Professor Rahman Awarded Google Grant to Engage Underrepresented Students in Computing Research
    Saturday, January 23, 2021, By Alex Dunbar
  • Special Collections Research Center Launches Latin American 45s Digital Collection
    Saturday, January 23, 2021, By Cristina Hatem
  • VPA Faculty to Present World Premieres at Society for New Music Concert Jan. 31
    Saturday, January 23, 2021, By News Staff
  • ‘Democracy on Trial: Can We Save It?’
    Friday, January 22, 2021, By News Staff

More In STEM

Professor Rahman Awarded Google Grant to Engage Underrepresented Students in Computing Research

Electrical engineering and computer science (EECS) Professor Farzana Rahman received a 2020 Google exploreCSR award to fund the development of an undergraduate student engagement workshop program, Research Exposure in Socially Relevant Computing (RESORC). The RESORC program will provide research opportunities…

Arts and Sciences Welcomes New Director of Forensics Kathleen Corrado

After 25 years working in the field of forensic science and over two decades of executive experience as a laboratory director, Kathleen Corrado has been named director of the Forensic and National Security Science Institute (FNSSI) in the College of…

Hehnly Lab Awarded $1.2M NIH Grant to Research Critical Tissue Formation

A key process during the development of an embryo is tissue morphogenesis, where the number of cells in an organism increase through cell division and tissues begins to take shape. Heidi Hehnly, assistant professor of biology, has been awarded a…

The Role of Digital Forensics and Tracking Down US Capitol Riot Criminals

With just under a week left before President-elect Joe Biden’s inauguration ceremony, investigators and law enforcement agencies across the country are working speedily to identify as many of the Jan. 6 U.S. Capitol riot offenders as they can. Knowing exactly…

A&S Researchers Awarded $2.1M Grant to Study Causes of Congenital Heart Defects

Congenital heart defects are the most common type of birth defect, affecting nearly 1 percent of births in the United States each year, according to the Centers for Disease Control and Prevention. Doctors have been unable to lower that number…

Subscribe to SU Today

If you need help with your subscription, contact sunews@syr.edu.

Connect With Us

  • Twitter
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
Social Media Directory

For the Media

Find an Expert Follow @SyracuseUNews
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • @SyracuseU
  • @SyracuseUNews
  • @SUCampus
  • Social Media Directory
  • Accessibility
  • Privacy
  • Campus Status
  • Syracuse.edu
© 2021 Syracuse University News. All Rights Reserved.